Literature DB >> 10530449

Bacteremic pneumococcal pneumonia in children.

P Toikka1, R Virkki, J Mertsola, P Ashorn, J Eskola, O Ruuskanen.   

Abstract

We carried out a nationwide retrospective study on bacteremic pneumococcal pneumonia diagnosed from 1985 to 1994 in Finland. The records of 85 children were reviewed for symptoms, signs, laboratory data, and response to antibiotic therapy. The chest radiographs were reevaluated. Bacteremic pneumococcal pneumonia was characterized by high fever (> or =39.0 degrees C in 93%), leukocytosis (WBC count on admission of > or =15x10(9)/L in 84%), and ill appearance (in 79%). Lobar or segmental consolidation was found in 79% of the chest radiographs. Of the patients, 28% had no respiratory symptoms, 6% presented with only gastrointestinal symptoms in addition to fever, and 4% had fever only. Tachypnea was recorded in 19% and rales in 14% of the patients. After onset of antimicrobial treatment, children became afebrile within an average of 22 hours. One patient developed pleural empyema, and none of the patients died.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530449     DOI: 10.1086/598635

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Streptococcus pneumoniae and Mycoplasma pneumoniae coinfection in community acquired pneumonia.

Authors:  P Toikka; T Juvén; R Virkki; M Leinonen; J Mertsola; O Ruuskanen
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

2.  Errors in registered birth weight and its implications for mortality statistics.

Authors:  D Anand; P O Pharoah
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

3.  Procalcitonin in children admitted to hospital with community acquired pneumonia.

Authors:  F Moulin; J Raymond; M Lorrot; E Marc; J Coste; J L Iniguez; G Kalifa; C Bohuon; D Gendrel
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

4.  Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children.

Authors:  E Lahti; J Mertsola; T Kontiokari; E Eerola; O Ruuskanen; J Jalava
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

5.  Differentiation of bacterial and viral pneumonia in children.

Authors:  R Virkki; T Juven; H Rikalainen; E Svedström; J Mertsola; O Ruuskanen
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 6.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 7.  Pneumococcal serology in children's respiratory infections.

Authors:  M Korppi; M Leinonen; O Ruuskanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-18       Impact factor: 3.267

8.  Procalcitonin predicts response to beta-lactam treatment in hospitalized children with community-acquired pneumonia.

Authors:  Jérémie F Cohen; Alexander Leis; Thibault Lecarpentier; Josette Raymond; Dominique Gendrel; Martin Chalumeau
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

Review 9.  Viral pneumonia.

Authors:  Olli Ruuskanen; Elina Lahti; Lance C Jennings; David R Murdoch
Journal:  Lancet       Date:  2011-03-22       Impact factor: 79.321

10.  Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture.

Authors:  Eiichi Nakayama; Keiko Hasegawa; Miyuki Morozumi; Reiko Kobayashi; Naoko Chiba; Taketoshi Iitsuka; Takeshi Tajima; Keisuke Sunakawa; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2007-10-30       Impact factor: 2.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.